Search clinical trials for: Bortezomib, Melphalan, Prednisone, Thalidomide
Total 221 results
-
Fondazione EMN Italy OnlusCompleted
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
PETHEMA FoundationCompleted
-
Central Hospital, Nancy, FranceTerminated
-
Janssen-Ortho Inc., CanadaOrtho Biotech CanadaNo longer available
-
Hackensack Meridian HealthMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Gruppo Italiano Studio LinfomiCompleted
-
Grupo de Estudos Multicentricos em Onco-HematologiaUnknown
-
Fondazione EMN Italy OnlusCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
Shanghai Jiao Tong University School of MedicineSuspended
-
Uppsala UniversityDalarna County Council, Sweden; Uppsala County Council, SwedenNot yet recruitingMyeloma Multiple
-
University Hospital, ToulouseMinistry of Health, France; Janssen, LPCompletedMultiple MyelomaFrance, Belgium
-
Dartmouth-Hitchcock Medical CenterMillennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Acute Myelogenous LeukemiaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMultiple MyelomaUnited States
-
Austrian Forum Against CancerCompleted
-
University of California, San FranciscoTerminatedMultiple Myeloma | Patient ParticipationUnited States
-
University of California, San FranciscoWithdrawn
-
University of Turin, ItalyCompleted
-
Intergroupe Francophone du MyelomeCompleted
-
University of ArkansasWithdrawnMultiple MyelomaUnited States
-
University Hospital HeidelbergGerman Cancer Research Center; Janssen-Cilag International NV; inVentiv Health... and other collaboratorsCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedNeurotoxicity | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Boston Medical CenterCompletedMultiple MyelomaUnited States
-
OncotherapeuticsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, France, Spain, Israel, India, Romania, Korea, Republic of, Singapore, Russian Federation, Poland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple MyelomaUnited States
-
Cigdem Sahinbas YILMAZTurkish Society of Hematology Myeloma Study GroupCompleted
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
Duke UniversityCompleted
-
Janssen Korea, Ltd., KoreaCompletedMultiple MyelomaKorea, Republic of
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Puerto Rico
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Emory UniversityMillennium Pharmaceuticals, Inc.Terminated
-
Basque Health ServiceTerminated
-
Peking UniversityAvailable
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research...Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
Roswell Park Cancer InstituteCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
MedsearchUnknownMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
AmgenCompletedMultiple MyelomaKorea, Republic of, China, Spain, Taiwan, United States, Netherlands, Australia, Singapore, New Zealand, United Kingdom, Israel, France, Japan, Italy, Czechia, Belgium, Argentina, Austria, Bulgaria, Canada, Germany, Greece, Hungary, M... and more
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Israel
-
Intergroupe Francophone du MyelomeJanssen Research & Development, LLC; HOVON - Dutch Haemato-Oncology AssociationActive, not recruitingMultiple MyelomaNetherlands, France, Belgium